Table of Contents :
• Stock Rating & Target Price
• Investment Thesis
• Fundamental Models Used
• Company Description
• Corporate Timeline
• Key Metrics (KPI ) and Recently Reported Earnings Review
• Business Highlights, Strategic Announcements & Outlook
• Quarter-over-Quarter (Q-o-Q) and Year-over-Year (Y-o-Y) Growth Analysis
• Key Catalysts Driving Growth
• Historical Financial Statement Analysis & CAGR Trends
• Quarterly Key Financial Ratios and Performance Metrics
• Annual Financial Performance Analysis: Horizontal and Vertical Financial Analysis, Trends
• Financial Forecasts
• Annual Forecasts: Income Statement
• Annual Forecasts: Cash Flow Statements
• Net Debt Levels
• A Closer Look at DCF: Our Assumptions and Methodology
• Terminal Value Calculation
• Target Price Analysis
• Valuation Multiples
• Supplementary Valuation Analysis: Multiples Approach
• Scenario/Sensitivity Analysis – Base Case , Bull Case ,Bear Case
• Holistic Peer Review & Trading Comps: Financial Data, Operational Metrics, and Valuation Multiples
• Implied Price Per Share
• Ownership Activity/ Insider Trades
• Ownership Summary
• An analysis of ESG Risk Rating
• Key Professionals
• Key Board Members
• Key Risks Considerations
• Analyst Ratings
• Analyst Industry Views
• Disclosures
Carlyle Group (CG): Flow Resilience vs. Scale Disadvantage, Can Capital Formation and Realizations Outweigh Tariff-Led Deployment Risk?
Carlyle’s Q1 2025 results affirm its disciplined execution and structural evolution into a fee-centric, capital-light compounder, with fee-related earnings rising 17% YoY to $311M at a record 48% margin, and distributable earnings reaching $455M. Strength in Carlyle AlpInvest and Global Credit—now contributing 50% of firm-wide FRE—reflects successful strategic mix-shifting, underpinned by scaled inflows into secondaries and European private lending. While Global Private Equity appreciated 18% YoY with $20B in LTM LP returns, realization cadence remains slower amid market friction, delaying carry recognition for CP VII. Nonetheless, Carlyle’s $453B AUM (+6% YoY) and $84B in dry powder provide optionality, especially in less-contested markets like Europe and Japan. Evergreen AUM surged 27% to $26B, Fortitude continues to scale reinsurance, and the capital markets business has already delivered $150M in fees over two quarters. While macro volatility and tariff headwinds could hamper monetization timing and LP commitments, management’s conservative posture—guiding 6% FRE growth and embedding no CP IX upside in 2025 outlook—adds credibility. With a structurally accretive model but valuation still discounted versus scaled peers, Carlyle’s near-term trajectory hinges on its ability to accelerate realizations and convert flows amid an externally cautious backdrop. Can Carlyle unlock sustained multiple expansion without the scale of its larger alt peers?
